glp 1 agonist lilly Medscape Advancements in Clinical Research and

doi: 10.1002/dmrr.2810

Even though patients with diabetic gastroparesis may feel full and may not want to eat, obtaining adequate nutrition is still important

These cases highlight the complexity of appetite regulation and the need for careful monitoring when using these medications

Cross-Trial Context# Retatrutide's 24.2% weight loss at 48 weeks appears numerically superior to semaglutide's 14.9% at 68 weeks, but several factors complicate direct comparison: Trial phase : Phase 2 trials often yield more favorable results than Phase 3 (smaller, more controlled populations) Treatment duration : Semaglutide data are at 68-104 weeks

The relationship between GLP-1 and hair loss is complex and likely multifaceted, involving various factors that may contribute to hair shedding